Skip to search formSkip to main contentSkip to account menu

Cyclophosphamide

Known as: CPM, 2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide, N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide 
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
The Microbiota Makes for Good Therapy The gut microbiota has been implicated in the development of some cancers, such as… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND Cyclophosphamide and glucocorticoids have been the cornerstone of remission-induction therapy for severe… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND We conducted a double-blind, randomized, placebo-controlled trial to determine the effects of oral cyclophosphamide on… 
Review
2005
Review
2005
SUMMARY Extended-spectrum β-lactamases (ESBLs) are a rapidly evolving group of β-lactamases which share the ability to hydrolyze… 
Highly Cited
2001
Highly Cited
2001
BACKGROUND The HER2 gene, which encodes the growth factor receptor HER2, is amplified and HER2 is overexpressed in 25 to 30… 
Highly Cited
1996
Highly Cited
1996
BACKGROUND Intravenous platinum-based chemotherapy is the standard primary therapy for advanced ovarian cancer. We conducted a… 
Highly Cited
1996
Highly Cited
1996
BACKGROUND Chemotherapy combinations that include an alkylating agent and a platinum coordination complex have high response… 
Highly Cited
1947
Highly Cited
1947
  • 1947
  • Corpus ID: 222064452